Skip to content

Nodal Upstaging in VATS Anatomical Resections for NSCLC

Cohort Analysis of Nodal Upstaging in the Era of Increase of VATS Anatomical Resections for NSCLC

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01985659
Enrollment
900
Registered
2013-11-15
Start date
2013-11-30
Completion date
2014-06-30
Last updated
2013-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma, Non-Small-Cell Lung

Keywords

Lymph Node Excision, Thoracic Surgical Procedures, Thoracic Surgery, Video-Assisted, Thoracotomy

Brief summary

This study investigates peropeative nodal upstaging during anatomical resections for non-small-cell-lung-cancer in an era of rising numbers of VATS anatomical resections. In case of comparable study groups, unchanged pretreatment staging and equal quality of pathologic examination, lymph node upstaging is a marker of surgical quality and can be used to study the quality of a new surgical technique.

Detailed description

Vats lobectomy is becoming the standard of care for early stage lung cancer. Several studies have shown feasibility and safety in dedicated centres. Compared to thoracotomy the procedure is believed to achieve equal oncologic results and survival, perhaps better. Publications have shown that mediastianal lymph node dissection during VATS is similar. However, two recent reports have shown potential lower N1 (hilar and intrapulmonary) upstaging in VATS surgery After optimal staging the percentage of unforeseen N+ the percentage of unforeseen positive nodes can reach 15% Nodal upstaging at final pathology is dependent on the quality of: * pretreatment staging, the better, the less upstaging * surgery, ie mediastinal, hilar and intrapulmonary lymphadenectomy * pathologic examination If we accept that pretreatment staging and pathologic examination are equal in two comparable surgical cohorts, the finding of unforeseen N+ or nodal upstaging is a quality marker of surgery. When surgical techniques are changing, it is important to look at this marker. In absence of a randomized trial, we believe a cohort analysis is useful. By including all patients, open or vats, and comparing cohorts instead of the surgical technique used, the selection bias is absent. We compare three cohorts. In the first (20007-2009) almost all patients where operated through a thoracotomy. In a second cohort, (2010-2011) the experience with vats was early. In the third period (2012-2013), a standardized vats technique with extensive intrapulmonary and mediastinal lymphadenectomy was used.

Interventions

None listed

Sponsors

University Hospital, Gasthuisberg
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All cN0, cN1 patients that underwent segmentectomy, lobectomy, sleeve lobectomy for NSCLC.

Exclusion criteria

* cN2 * cM+ * Pneumonectomy * Previous lung cancer surgery - lymphadenectomy * Neo-adjunvant therapy * Lung Tx * Bilateral lesions

Design outcomes

Primary

MeasureTime frameDescription
proportion of N upstagingat time of surgical resectionclinical N0 to pathological N1 clinical N0 to pathological N2 clinical N1 to pathological N2

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026